1/13/2014 10:44:50 AM
ST. LOUIS, Mo.--(BUSINESS WIRE)--Mallinckrodt (NYSE: MNK) announced today that it has entered into a multiyear agreement with Medtronic (NYSE: MDT) to advance availability in the U.S. of intrathecal therapeutics for the treatment of chronic pain and severe spasticity.
Help employers find you! Check out all the jobs and post your resume.
comments powered by